(4S)-N-[4-(carbamoylamino)butyl]-4-[(3S,5R,7S,8S,9R,10R,13S,14R,17S)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanamide

C29H51N3O4 — CID 171117896

IUPAC(4S)-N-[4-(carbamoylamino)butyl]-4-[(3S,5R,7S,8S,9R,10R,13S,14R,17S)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanamide
SMILESC[C@@H](CCC(=O)NCCCCNC(N)=O)[C@@H]1CC[C@@H]2[C@@H]3[C@@H](CC[C@]21C)[C@]1(C)CC[C@H](O)C[C@@H]1C[C@@H]3O
InChIInChI=1S/C29H51N3O4/c1-18(6-9-25(35)31-14-4-5-15-32-27(30)36)21-7-8-22-26-23(11-13-29(21,22)3)28(2)12-10-20(33)16-19(28)17-24(26)34/h18-24,26,33-34H,4-17H2,1-3H3,(H,31,35)(H3,30,32,36)/t18-,19+,20-,21-,22+,23+,24-,26+,28+,29-/m0/s1
InChIKeyLXUDEAPTHWYHGD-LXGCUHHVSA-N
MW505.74 g/mol
LogP3.96
Rot. Bonds9

About (4S)-N-[4-(carbamoylamino)butyl]-4-[(3S,5R,7S,8S,9R,10R,13S,14R,17S)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanamide

(4S)-N-[4-(carbamoylamino)butyl]-4-[(3S,5R,7S,8S,9R,10R,13S,14R,17S)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanamide (PubChem CID 171117896) has the molecular formula C29H51N3O4 and a molecular weight of 505.74 g/mol. Its IUPAC name is (4S)-N-[4-(carbamoylamino)butyl]-4-[(3S,5R,7S,8S,9R,10R,13S,14R,17S)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanamide.

Molecular Properties

Compound Name(4S)-N-[4-(carbamoylamino)butyl]-4-[(3S,5R,7S,8S,9R,10R,13S,14R,17S)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanamide
PubChem CID171117896
Molecular FormulaC29H51N3O4
Molecular Weight505.74 g/mol
Exact Mass505.39
IUPAC Name(4S)-N-[4-(carbamoylamino)butyl]-4-[(3S,5R,7S,8S,9R,10R,13S,14R,17S)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanamide
SMILESC[C@@H](CCC(=O)NCCCCNC(N)=O)[C@@H]1CC[C@@H]2[C@@H]3[C@@H](CC[C@]21C)[C@]1(C)CC[C@H](O)C[C@@H]1C[C@@H]3O
InChIInChI=1S/C29H51N3O4/c1-18(6-9-25(35)31-14-4-5-15-32-27(30)36)21-7-8-22-26-23(11-13-29(21,22)3)28(2)12-10-20(33)16-19(28)17-24(26)34/h18-24,26,33-34H,4-17H2,1-3H3,(H,31,35)(H3,30,32,36)/t18-,19+,20-,21-,22+,23+,24-,26+,28+,29-/m0/s1
InChIKeyLXUDEAPTHWYHGD-LXGCUHHVSA-N
XLogP3.96
TPSA124.68 Ų
H-Bond Donors5
H-Bond Acceptors4
Rotatable Bonds9
Heavy Atoms36
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500505.74
LogP ≤ 53.96
H-Bond Donors ≤ 55
H-Bond Acceptors ≤ 104

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze (4S)-N-[4-(carbamoylamino)butyl]-4-[(3S,5R,7S,8S,9R,10R,13S,14R,17S)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (4S)-N-[4-(carbamoylamino)butyl]-4-[(3S,5R,7S,8S,9R,10R,13S,14R,17S)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanamide?
The IUPAC name of (4S)-N-[4-(carbamoylamino)butyl]-4-[(3S,5R,7S,8S,9R,10R,13S,14R,17S)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanamide (CID 171117896) is (4S)-N-[4-(carbamoylamino)butyl]-4-[(3S,5R,7S,8S,9R,10R,13S,14R,17S)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanamide.
What is the SMILES notation for (4S)-N-[4-(carbamoylamino)butyl]-4-[(3S,5R,7S,8S,9R,10R,13S,14R,17S)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanamide?
The canonical SMILES for (4S)-N-[4-(carbamoylamino)butyl]-4-[(3S,5R,7S,8S,9R,10R,13S,14R,17S)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanamide is C[C@@H](CCC(=O)NCCCCNC(N)=O)[C@@H]1CC[C@@H]2[C@@H]3[C@@H](CC[C@]21C)[C@]1(C)CC[C@H](O)C[C@@H]1C[C@@H]3O.
What is the InChIKey of (4S)-N-[4-(carbamoylamino)butyl]-4-[(3S,5R,7S,8S,9R,10R,13S,14R,17S)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanamide?
The InChIKey is LXUDEAPTHWYHGD-LXGCUHHVSA-N. The full InChI is InChI=1S/C29H51N3O4/c1-18(6-9-25(35)31-14-4-5-15-32-27(30)36)21-7-8-22-26-23(11-13-29(21,22)3)28(2)12-10-20(33)16-19(28)17-24(26)34/h18-24,26,33-34H,4-17H2,1-3H3,(H,31,35)(H3,30,32,36)/t18-,19+,20-,21-,22+,23+,24-,26+,28+,29-/m0/s1.
What are the key properties of (4S)-N-[4-(carbamoylamino)butyl]-4-[(3S,5R,7S,8S,9R,10R,13S,14R,17S)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanamide?
(4S)-N-[4-(carbamoylamino)butyl]-4-[(3S,5R,7S,8S,9R,10R,13S,14R,17S)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanamide has a molecular weight of 505.74 g/mol, XLogP of 3.96, 9 rotatable bonds, 5 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for (4S)-N-[4-(carbamoylamino)butyl]-4-[(3S,5R,7S,8S,9R,10R,13S,14R,17S)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanamide is sourced from PubChem (CID 171117896), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).